Stem Cells GVHD

Are there stem cell therapies available for GVHD? Health Canada and the U.S. Food and Drug Administration have granted conditional approval for Prochymal, a mesenchymal stem cell product, for the treatment of steroid-resistant and/or immunosuppressant-resistant acute graft-versus-host disease (GVHD) in pediatric patients. Final approval depends on the outcome of clinical studies that are underway. Patients who …

WeiterlesenStem Cells GVHD

Stem Cells Blood Disorders

Are there stem cell treatments available for blood disorders? Yes. Hematopoietic stem cell transplants from bone marrow, umbilical cord and peripheral blood are approved by Health Canada and the FDA to help treat a variety of different blood-based cancers including multiple myeloma, leukemia and lymphoma, and other blood disorders, including anemia, thalassemia and severe combined …

WeiterlesenStem Cells Blood Disorders

Stem Cell Brain Cancer

A “Dream Team” of top Canadian scientists, led by two outstanding figures in stem cell research, is launching a new attack on brain cancers. The team, announced today in Toronto, will receive $11.7 million over four years from Stand Up To Cancer Canada (SU2C), Genome Canada, the Canadian Institutes of Health Research, the Cancer Stem Cell Consortium, and …

WeiterlesenStem Cell Brain Cancer

Canadian Stem Cell Strategy

The next decade will see a flood of novel and improved treatments for diseases and injuries that have baffled medical science for centuries. These treatments will lead to more effective therapies for chronic conditions that are pushing our health care system beyond sustainability. The Strategy, In Brief Following Through: Realizing The Promise of Stem Cells …

WeiterlesenCanadian Stem Cell Strategy